Disease/Infection News

RSS

Study reports persistent SARS-CoV-2 with increasing viral variants in pediatric patients

New research, published on medRxiv preprint server, has reported the effect of prolonged SARS-CoV-2 infection in immunocompromised children and young adults.

4 Mar 2021

Researchers call for more awareness relating to delayed skin reactions to Moderna COVID-19 vaccine

As the speed and scale of vaccinations against the SARS-CoV-2 virus ramps up globally, researchers at Massachusetts General Hospital (MGH) are calling for greater awareness and communication around a delayed injection-site reaction that can occur in some patients who have received the Moderna mRNA-1273 vaccine.

3 Mar 2021

COVID-19 pandemic had major impacts on childhood cancer care, shows survey

The COVID-19 pandemic has had major impacts on childhood cancer care worldwide, according to a survey of more than 300 clinicians from 200 hospitals worldwide published in The Lancet Child & Adolescent Health journal.

3 Mar 2021

SARS-CoV-2 variants do not substantially affect CD4+ and CD8+ T cell responses, study shows

Researchers from California in the United States have conducted a study showing that important adaptive immune responses to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are not affected by four recently emerged variants of the virus.

3 Mar 2021

Researchers lay out bioinformatics bottlenecks that are hindering response to COVID-19 pandemic

A global group of researchers is calling for better integration of viral genetics, bioinformatics, and public health to enable better pandemic response now and better pandemic preparedness in the future.

3 Mar 2021

Wikipedia maintained high-quality COVID-19 coverage during first pandemic wave

Researchers in Israel have demonstrated that Wikipedia's coverage of the coronavirus disease 2019 (COVID-19) pandemic continued to be based on respected media and academic sources, despite a surge in coverage as the pandemic grew during the first wave.

3 Mar 2021

Study shows lower antibody cross-reactivity after infection with the B.1.1.7 SARS-CoV-2 variant

In a recent research paper currently available on the bioRxiv* preprint server, a diverse group of researchers has examined the immunogenicity of antibodies against the variant B.1.1.7 of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) initially found in the United Kingdom – and revealed diminished recognition and neutralization of either parental strains or the South African variant.

3 Mar 2021

COVID risk to households and teachers from in person schooling

When researchers analyzed the responses of the COVID-19 Symptom Survey in the United States, they found an increased risk of COVID-19 for household members when children had in-person schooling.

3 Mar 2021

Results from phase 2 trial of Novavax recombinant nanoparticle SARS-CoV-2 vaccine

Novavax, Inc., the American vaccine development company, has been developing a recombinant protein nanoparticle COVID-19 vaccine currently termed NVX-CoV2373. The full-length spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is created in a baculovirus vector, which is then inserted into a lipid nanoparticle around 50 nm in diameter.

3 Mar 2021

Genetic variation associated with COVID-19 outcome

Host genetics play a role in disease progression and prognosis. A paper recently uploaded to the preprint server medRxiv by Dubé et al. (1st March 2021) identifies several alleles associated with the gene natriuretic peptide receptor C (NPR3) that may impact disease severity.

3 Mar 2021

Liquid-handling robots for wastewater surveillance help predict COVID-19 cases in San Diego

In earlier days of the COVID-19 pandemic, before diagnostic testing was widely available, it was difficult for public health officials to keep track of the infection's spread, or predict where outbreaks were likely to occur.

3 Mar 2021

Low-cost, non-electric ventilator allows non-specialized workers to treat COVID-19 patients

A team of engineers from Loughborough University has designed and built a unique low-cost, non-electric ventilator in response to the COVID-19 pandemic.

3 Mar 2021

Scientists search for new ways to fight against fungal infections

Systemic fungal infections are much rarer than other illnesses, but they are potentially deadly, with limited options for treatment.

3 Mar 2021

Pfizer SARS-CoV-2 vaccine effective from day 11 post 1st vaccination

New research from a team of scientists in Australia finds that the second ‘booster’ dose of the Pfizer-BioNTech vaccine did not increase vaccine efficacy against severe acute respiratory syndrome (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19). The results suggest one dose of the vaccine was sufficient in providing a robust immune response 11 days after inoculation.

3 Mar 2021

Report: Probabilistic forecasts of the impact of vaccines and variants on the U.S. COVID trajectory

In a report summary released today Thomas McAndrew, a computational scientist and assistant professor at Lehigh University's College of Health includes probabilistic forecasts of the impact of vaccines and variants on the U.S. COVID trajectory over the next few weeks.

3 Mar 2021

Researchers to investigate COVID-19's disproportionate impact on long-term care residents and workers

Long-term care facilities have been disproportionately burdened by COVID-19, accounting for about 60% of COVID-19 deaths nationwide, 70% if retirement homes are included.

3 Mar 2021

New substance suppresses the growth of harmful bacteria that cause periodontitis

Targeted, efficient and with few side effects: A new method for combating periodontitis could render the use of broad-spectrum antibiotics superfluous.

3 Mar 2021

Study: Less than 2% of COVID-19 patients suffered an ischemic stroke

A review of nearly 28,000 emergency department records shows less than 2% of patients diagnosed with COVID-19 suffered an ischemic stroke but those who did had an increased risk of requiring long-term care after hospital discharge.

3 Mar 2021

Vaccine candidate shows promise to protect against dozen-plus flu strains

Ask Eric Weaver about pandemics, and he's quick to remind you of a fact that illustrates the fleeting nature of human memory and the proximal nature of human attention: The first pandemic of the 21st century struck not in 2019, but 2009.

3 Mar 2021

UK public health authorities review early data on the effectiveness of Pfizer and AstraZeneca COVID-19 vaccines

A team of UK scientists has recently evaluated the effectiveness of the Pfizer (BNT162b2) and AstraZeneca (ChAdOx1) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The findings reveal that both vaccines are effective in significantly reducing SARS-CoV-2 infection in older adults and providing long-term protection.

3 Mar 2021

Disease/Infection News

Study reports persistent SARS-CoV-2 with increasing viral variants in pediatric patients

Researchers call for more awareness relating to delayed skin reactions to Moderna COVID-19 vaccine

COVID-19 pandemic had major impacts on childhood cancer care, shows survey

SARS-CoV-2 variants do not substantially affect CD4+ and CD8+ T cell responses, study shows

Researchers lay out bioinformatics bottlenecks that are hindering response to COVID-19 pandemic

Wikipedia maintained high-quality COVID-19 coverage during first pandemic wave

Study shows lower antibody cross-reactivity after infection with the B.1.1.7 SARS-CoV-2 variant

COVID risk to households and teachers from in person schooling

Results from phase 2 trial of Novavax recombinant nanoparticle SARS-CoV-2 vaccine

Genetic variation associated with COVID-19 outcome

Liquid-handling robots for wastewater surveillance help predict COVID-19 cases in San Diego

Low-cost, non-electric ventilator allows non-specialized workers to treat COVID-19 patients

Scientists search for new ways to fight against fungal infections

Pfizer SARS-CoV-2 vaccine effective from day 11 post 1st vaccination

Report: Probabilistic forecasts of the impact of vaccines and variants on the U.S. COVID trajectory

Researchers to investigate COVID-19's disproportionate impact on long-term care residents and workers

New substance suppresses the growth of harmful bacteria that cause periodontitis

Study: Less than 2% of COVID-19 patients suffered an ischemic stroke

Vaccine candidate shows promise to protect against dozen-plus flu strains

UK public health authorities review early data on the effectiveness of Pfizer and AstraZeneca COVID-19 vaccines

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Latest News